Investment Analysts’ Updated EPS Estimates for August, 18th (BMA, CCXI, CPCAY, CPSS, CRMD, CRRFY, CRVS, CRWS, CVGW, DATA)

Investment Analysts’ updated eps estimates for Friday, August 18th:

Macro Bank (NYSE:BMA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Banco Macro Bansud is a leading bank in Argentina. With the most extensive private-sector branch network in the country, Banco Marco provides standard banking products and services to a nationwide customer base. “

ChemoCentryx (NASDAQ:CCXI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California. “

Cathay Pacific Airways (OTCMKTS:CPCAY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CATHAY PACIFIC AIRWAY’s principal activity is the operation of an international airline based and registered in Hong Kong. Other activities include airline catering, aircraft handling and engineering. The Group offers scheduled passenger and cargo services to 62 destinations around the world. It operates in Hong Kong, Mainland China, Japan, Korea, Taiwan, South East Asia, Middle East, Europe, Pacific and South Africa. “

Consumer Portfolio Services (NASDAQ:CPSS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CONSUMER PORTFOLIO SERVICES is a consumer finance company that specializes in purchasing, selling, and servicing contracts with purchases of vechicles who are sub prime borrowers and are unable to obtain credit from traditional sources. “

CorMedix (NYSEMKT:CRMD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications. The Company’s therapeutic candidates for cardiorenal disease may be small molecules, biologicals, devices and/or diagnostics (tests) that enable therapy. Its product pipeline includes: CRMD001, a unique formulation Deferiprone which is in development to prevent Contrast-Induced Acute Kidney Injury and to slow progression of Chronic Kidney Disease; CRMD002, a diagnostic test for urinary labile iron; CRMD003 (Neutrolin®, an antimicrobial/anticoagulant solution) is in development to prevent Catheter Related Bloodstream Infection; CRMD004, a pressure sensitive gel which has many uses, including extending the benefits of Neutrolin®. CorMedix Inc. is based in Summit, New Jersey. “

Carrefour Sa Spon (NASDAQ:CRRFY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Carrefour S.A. operates hypermarkets, supermarkets, convenience stores and cash and carry stores in Europe, the Americas and Asia. Carrefour S.A. is headquartered in Boulogne-Billancourt, France. “

Corvus Pharmaceuticals (NASDAQ:CRVS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California. “

Crown Crafts (NASDAQ:CRWS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Crown Crafts, Inc. operates, both directly and indirectly through its subsidiaries, in two principal business segments within the textile industry: Adult Home Furnishing and Juvenile Products, and Infant Products. Adult Home Furnishing and Juvenile Products consists of Bedroom Products, Throws and Decorative Home Accessories, and Juvenile Products. The Infant Products segment consists of infant bedding, bibs, infant soft goods and accessories. “

Calavo Growers (NASDAQ:CVGW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Calavo Growers, Inc. engages in the procurement and marketing of avocados and other perishable foods and the preparation and distribution of processed avocado products. Their expertise in marketing and distributing avocado, processed avocado, and other perishable foods allows them to deliver a wide array of fresh and processed food products to food distributors, produce wholesalers, supermarkets, and restaurants on a worldwide basis. “

Tableau Software (NYSE:DATA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Tableau Software, Inc. engages in providing analytics and data visualization software. The company offers Tableau Desktop, Tableau Server and Tableau Public. It also provides related maintenance and support, and professional and training services. The Company’s product helps a single user on a laptop analyze data from a simple spreadsheet, or to enable thousands of users across an enterprise to execute queries against databases. Tableau Software, Inc. is headquartered in Seattle, Washington. “

Digital Ally (NASDAQ:DGLY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Digital Ally was created to supply technology based products to the law enforcement and security industry. While their main concentration is in the development and application of new concepts, they also recognize the value of retrofitting existing installations with cost-effective digital sub-systems. This flexibility allows to compete in established markets as they simultaneously promote the industry’s transition towards advanced technologies. “

Erste Group Bank AG (OTCMKTS:EBKDY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “The Erste Bank der Muster is a traditional banking group and providering financial services in Central and Eastern Europe. It focuses on retail and SME banking. It offers a range of products through group-wide bundling of product know how into Competence Centres covering, among others, Debt financing, Equity capital markets ,Mergers and acquisitions,Debt advisory, Project financing, Syndication, Real Estate financing and solutions, Infrastructure Finance & Public Sector, Merchant Banking / Private Equity, Leasing solutions (IMMORENT), and Corporate Cash Management. Its customers can avail its products in netbanking, wether it is Komfort-Kredit, Profit account, Bonus account, Building society contract, Pension plan or the order of MasterCard or VISA Card. Erste Bank focuses on private clients, corporate clients and the public sector. it offers all financial products under one roof. It operates in the areas of investment , construction and living , and leasing. Erste Bank is based in Vienna, Austria. “

Estee Lauder Companies, Inc. (The) (NYSE:EL) was given a $108.00 target price by analysts at Stifel Nicolaus. The firm currently has a buy rating on the stock.

Newfield Exploration (NYSE:NFX) was given a $37.00 price target by analysts at Stifel Nicolaus. The firm currently has a buy rating on the stock.